GlassScriptPhysician profile
Debapria Das
NPI 1215431820
$6,330.35
in general payments reported to CMS, 2019-2025
13 companies · $1,812 in 2025
The $1,812 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $64.08 · 2022: $191 · 2023: $3,207 · 2024: $1,056 · 2025: $1,812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,658 · Travel and Lodging: $2,086 · Education: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,657.62 |
| Travel and Lodging | $2,086.46 |
| Education | $331.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,550.78 | 2023-2024 | Impella |
| Abbott Laboratories | $2,425.73 | 2023-2025 | Optis, Cardiomems, Perclose Prostyle |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $412.98 | 2021-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $235.86 | 2023-2024 | Camzyos |
| Boston Scientific Corporation | $220.61 | 2023-2025 | Ekosonic, Watchman Access System, Synergy |
| Shockwave Medical, INC | $203.32 | 2025 | |
| Angiodynamics, INC. | $69.41 | 2023-2025 | Alphavac, Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $68.80 | 2024 | Onyx Frontier |
| Reflow Medical INC | $52.68 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $32.76 | 2025 | Uptravi, Opsynvi |
| Getinge USA Sales, LLC | $23.71 | 2023 | Cardiosave Hybrid, Type B Plug |
| Terumo Medical Corporation | $20.03 | 2025 | Angio-Seal, Metacross Otw |
| Amgen INC. | $13.68 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debapria Das listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.